|
|
|
Volumn 91, Issue SUPPL. 3, 1996, Pages 68-70
|
|
Phase I clinical studies in oncology and hematology. Concepts, realization and ethical considerations;KLINISCHE PHASE-I-STUDIEN IN ONKOLOGIE UND HAMATOLOGIE. KONZEPTION, DURCHFUHRUNG UND ETHISCHE UBERLEGUNGEN
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
HEMATOLOGY;
HUMAN;
PHASE 1 CLINICAL TRIAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE I;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
ETHICS, MEDICAL;
HUMANS;
LEUKEMIA;
LYMPHOMA;
NEOPLASMS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 0029884958
PISSN: 07235003
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
